BELLUS Health
NASDAQOTH:BLUS.PK
$0.04
$0.00
(0.00%)
Quote as of 1:25 PM EST on 02/10/12
|
$0.04
$0.00
(0.00%)
|
|
| Today's Open | $0.04 |
|---|---|
| Previous Close | $0.04 |
| Daily Range | $0.04 - $0.04 |
| 52-Week Range | $0.01 - $0.17 |
| Market Cap | $7.98M |
| P/E Ratio | -0.95 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 200 |
| Average Daily Volume | 117,300 |
| Current FY EPS | $0.00 |
BLUS.PK Information
| Description |
|---|
| A biopharmaceutical company focused on the development and commercialization of innovative therapeutics to address critical unmet medical needs. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Bellus Health starts selling Vivimind in Canada
Bellus Health earns $245,000 in Q3 2011
BELLUS Health reports results for second quarter ended June 30, 2011
Crystal Research Associates Issues Research Report on BELLUS Health Inc. (TOR:BLU)
Quebec No. 2 Holdings, LLC: Acquisition of Shares of BELLUS Health Inc.
Quebec No. 2 Holdings, LLC: Acquisition of Shares of BELLUS Health Inc.
Quebec No. 2 Holdings, LLC: Acquisition of Shares of BELLUS Health Inc.
